CLINICAL_TRIALS
trial_result
· 2019-11-01
Clinical Trial Update: Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs [Phase 4]
Summary
Phase 4 trial comparing Belsomra at 10 mg and 20 mg to placebo in non-elderly adults with insomnia completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Henry Ford Health System | Conditions: Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2019-11-01